PharmEnable Therapeutics is reimagining small molecule drug discovery by harnessing AI to unlock the vastness of chemical space and deliver more effective medicines. 

Biology defines the challenge and chemSEEK™, our proprietary AI platform, designs the small molecule solution to treat it. By decoding the pharmacological needs of a target and exploring previously untapped chemical space, chemSEEK™ designs novel, diverse, and highly synthesisible molecules from first principles. Enabling access to data-sparse targets, chemSEEK™ accelerates the discovery of more effective medicines with superior selectivity and drug-like properties.

With an exciting pre-clinical pipeline of wholly-owned and partnered programs, we are harnessing chemSEEK™ to create first- and best-in-class small molecule medicines in areas of urgent medical need.